| Patient | John Henry Holliday |
|---|---|
| Date of birth | 2004-08-14 |
| Identifiers | MRN HR-NI007-SYN; SSN (made up) 000-07-8153 |
| Document date | 2026-02-10 |
| Author | Martin Beaumont, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for diagnosis of cavitary pulmonary tuberculosis: sputum, chest X-ray, baseline tests, public-health report, home isolation, and alcohol assessment with a safety assessment. [S]
Hemoglobin: 12.6 g/dL (low); White cell count: 9.4 10*3/uL; Platelets: 412 10*3/uL (high); ALT: 34 U/L; AST: 38 U/L; Total bilirubin: 0.6 mg/dL; Alkaline phosphatase: 92 U/L; GGT: 78 U/L (high); Albumin: 3.4 g/dL (low); Creatinine: 0.86 mg/dL; eGFR: 124 mL/min/1.73 m²; Glucose: 90 mg/dL; HbA1c: 5.2%; Visual acuity, right eye (ETDRS letters): 85; Visual acuity, left eye (ETDRS letters): 85; AUDIT: 15; AUDIT-C: 9; PHQ-9: 6. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-02-10 | Body height | 178 | cm | S |
| 2026-02-10 | Body weight | 58 | kg | S |
| 2026-02-10 | Body mass index (BMI) [Ratio] | 18.3 | kg/m2 | S |
| 2026-02-10 | Systolic blood pressure | 112 | mm[Hg] | S |
| 2026-02-10 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-02-10 | Heart rate | 104 | /min | S |
| 2026-02-10 | Respiratory rate | 20 | /min | S |
| 2026-02-10 | Body temperature | 37.8 | Cel | S |
| 2026-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-02-10 | Hemoglobin [Mass/volume] in Blood | 12.6 | g/dL | 13.2-16.6 g/dL | Low | S |
| 2026-02-10 | Leukocytes [#/volume] in Blood by Automated count | 9.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-02-10 | Platelets [#/volume] in Blood by Automated count | 412 | 10*3/uL | 150-400 10*3/uL | High | S |
| 2026-02-10 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 34 | U/L | 7-56 U/L | Normal | S |
| 2026-02-10 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 | U/L | 10-40 U/L | Normal | S |
| 2026-02-10 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-02-10 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 92 | U/L | 40-129 U/L | Normal | S |
| 2026-02-10 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 78 | U/L | 8-61 U/L | High | S |
| 2026-02-10 | Albumin [Mass/volume] in Serum or Plasma | 3.4 | g/dL | 3.5-5 g/dL | Low | S |
| 2026-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 0.86 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-02-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 124 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-02-10 | Glucose [Mass/volume] in Serum or Plasma | 90 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-02-10 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.2 | % | <=5.6% | Normal | S |
| 2026-02-10 | Visual acuity uncorrected Right eye by ETDRS eye chart | 85 | {letters} | >=80 | Normal | S |
| 2026-02-10 | Visual acuity uncorrected Left eye by ETDRS eye chart | 85 | {letters} | >=80 | Normal | S |
| 2026-02-10 | Total score [AUDIT] | 15 | {score} | S | ||
| 2026-02-10 | Total score [AUDIT-C] | 9 | {score} | S | ||
| 2026-02-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Pulmonary tuberculosis, right upper lobe cavitary, sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistance | active | confirmed | A15.0 | S — Synthetic modern coding of his documented pulmonary tuberculosis at the time of diagnosis; the bacteriology is synthetic. |
| Alcohol use disorder, mild, with binge drinking | active | confirmed | F10.10 | S — Synthetic modern coding anchored to the documented heavy drinking; the severity and the criteria met are synthetic. |